0001768446-19-000002.txt : 20191023 0001768446-19-000002.hdr.sgml : 20191023 20191023113209 ACCESSION NUMBER: 0001768446-19-000002 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20191023 DATE AS OF CHANGE: 20191023 EFFECTIVENESS DATE: 20191023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Eliem Therapeutics, Inc. CENTRAL INDEX KEY: 0001768446 IRS NUMBER: 832273741 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-333123 FILM NUMBER: 191163142 BUSINESS ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 617-778-2500 MAIL ADDRESS: STREET 1: 200 BERKELEY STREET STREET 2: 18TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D/A 1 primary_doc.xml X0708 D/A LIVE 0001768446 Eliem Therapeutics, Inc. 200 BERKELEY STREET 18TH FLOOR BOSTON MA MASSACHUSETTS 02116 617-778-2500 DELAWARE None None Corporation true 2018 Andrew Levin 200 Berkeley Street 18th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Director David-Alexandre Gros 17511 Los Morros #2283 Ranchero Santa Fe CA CALIFORNIA 92067 Director Simon Tate 20 Station Road Cambridge X0 UNITED KINGDOM CB1 2JD Director Valerie Morisset 200 Berkeley Street 18th Floor Boston MA MASSACHUSETTS 02116 Executive Officer Pharmaceuticals Decline to Disclose 06b true 0001567619-19-004873 2019-02-04 false true false 0 16302501 16302501 0 false 6 0 0 0 false Eliem Therapeutics, Inc. Andrew Levin Andrew Levin Chief Executive Officer 2019-10-23